CH667994A5 - Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen. - Google Patents

Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen. Download PDF

Info

Publication number
CH667994A5
CH667994A5 CH2138/86A CH213886A CH667994A5 CH 667994 A5 CH667994 A5 CH 667994A5 CH 2138/86 A CH2138/86 A CH 2138/86A CH 213886 A CH213886 A CH 213886A CH 667994 A5 CH667994 A5 CH 667994A5
Authority
CH
Switzerland
Prior art keywords
pharmaceutical compositions
compositions according
somatostatin
administration
sms
Prior art date
Application number
CH2138/86A
Other languages
German (de)
English (en)
Inventor
Jacky Vonderscher
Joachim Dr Franz
Michel Dr Steiger
Karl Dr Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH2138/86A priority Critical patent/CH667994A5/de
Priority to NL8701143A priority patent/NL8701143A/nl
Priority to HU872150A priority patent/HU198626B/hu
Priority to DE19873716437 priority patent/DE3716437A1/de
Priority to PCT/CH1987/000056 priority patent/WO1987007149A1/de
Priority to GB8712193A priority patent/GB2190838B/en
Priority to FR878707368A priority patent/FR2599254B1/fr
Priority to BE8700598A priority patent/BE1000722A4/fr
Priority to CA000537928A priority patent/CA1299495C/en
Priority to PT84943A priority patent/PT84943B/pt
Priority to FI872313A priority patent/FI872313A/fi
Priority to NZ220418A priority patent/NZ220418A/xx
Priority to IT8747977A priority patent/IT1216814B/it
Priority to NO872174A priority patent/NO171484C/no
Priority to SE8702188A priority patent/SE8702188L/
Priority to GR870820A priority patent/GR870820B/el
Priority to AU73364/87A priority patent/AU601740B2/en
Priority to DK265587A priority patent/DK265587A/da
Priority to MYPI87000714A priority patent/MY101233A/en
Priority to IL82645A priority patent/IL82645A0/xx
Priority to KR870005303A priority patent/KR870010870A/ko
Priority to LU86901A priority patent/LU86901A1/fr
Priority to JP62129572A priority patent/JPS62283930A/ja
Priority to ZA873841A priority patent/ZA873841B/xx
Priority to ES8701555A priority patent/ES2008126A6/es
Priority to CH165/88A priority patent/CH669909A5/de
Publication of CH667994A5 publication Critical patent/CH667994A5/de
Priority to FR8907995A priority patent/FR2630916B1/fr
Priority to US08/008,383 priority patent/US5393738A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CH2138/86A 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen. CH667994A5 (de)

Priority Applications (28)

Application Number Priority Date Filing Date Title
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
NL8701143A NL8701143A (nl) 1986-05-27 1987-05-13 Farmaceutische preparaten.
HU872150A HU198626B (en) 1986-05-27 1987-05-13 Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
DE19873716437 DE3716437A1 (de) 1986-05-27 1987-05-16 Pharmazeutische zusammensetzung
PCT/CH1987/000056 WO1987007149A1 (en) 1986-05-27 1987-05-22 Pharmaceutical compositions
GB8712193A GB2190838B (en) 1986-05-27 1987-05-22 Pharmaceutical compositions
NO872174A NO171484C (no) 1986-05-27 1987-05-25 Anvendelse av sukkeralkohol, polyoksyalkyleneter eller etmonosakkarid eller blandinger derav som baerer for somatostatiner og kalsitoniner for aa oeke biotilgjengeligheten av peptidene ved oral eller rektal tilfoersel
DK265587A DK265587A (da) 1986-05-27 1987-05-25 Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption
CA000537928A CA1299495C (en) 1986-05-27 1987-05-25 Pharmaceutical composition containing polypeptide
PT84943A PT84943B (pt) 1986-05-27 1987-05-25 Processo para a preparacao de composicoes farmaceuticas contendo uma mistura de pelo menos, um polipeptido, um monossacarido e um polioxialquileno-eter
FI872313A FI872313A (fi) 1986-05-27 1987-05-25 Farmaceutiska kompositioner.
NZ220418A NZ220418A (en) 1986-05-27 1987-05-25 A pharmaceutical composition adapted for g.i. resorption comprising a polypeptide and a monosaccharide or sugar alcohol and/or a polyoxylakylene ether
IT8747977A IT1216814B (it) 1986-05-27 1987-05-25 Composizioni farmaceutiche
FR878707368A FR2599254B1 (fr) 1986-05-27 1987-05-25 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale.
SE8702188A SE8702188L (sv) 1986-05-27 1987-05-25 Farmaceutiska kompositioner
GR870820A GR870820B (en) 1986-05-27 1987-05-25 Pharmaceutical compositions
AU73364/87A AU601740B2 (en) 1986-05-27 1987-05-25 Pharmaceutical compositions
BE8700598A BE1000722A4 (fr) 1986-05-27 1987-05-25 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale.
MYPI87000714A MY101233A (en) 1986-05-27 1987-05-25 Pharmaceutical compositions
IL82645A IL82645A0 (en) 1986-05-27 1987-05-25 Pharmaceutical compositions containing polypeptides
KR870005303A KR870010870A (ko) 1986-05-27 1987-05-26 약학 조성물의 제조방법
LU86901A LU86901A1 (fr) 1986-05-27 1987-05-26 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
JP62129572A JPS62283930A (ja) 1986-05-27 1987-05-26 医薬組成物
ZA873841A ZA873841B (en) 1986-05-27 1987-05-27 Pharmaceutical compositions
ES8701555A ES2008126A6 (es) 1986-05-27 1987-05-27 Procedimiento para la preparacion de una composicion farmaceutica a base de polipeptidos
CH165/88A CH669909A5 (ja) 1986-05-27 1988-05-22
FR8907995A FR2630916B1 (fr) 1986-05-27 1989-06-14 Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale
US08/008,383 US5393738A (en) 1986-05-27 1993-01-25 Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Publications (1)

Publication Number Publication Date
CH667994A5 true CH667994A5 (de) 1988-11-30

Family

ID=4226759

Family Applications (2)

Application Number Title Priority Date Filing Date
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
CH165/88A CH669909A5 (ja) 1986-05-27 1988-05-22

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH165/88A CH669909A5 (ja) 1986-05-27 1988-05-22

Country Status (5)

Country Link
JP (1) JPS62283930A (ja)
CH (2) CH667994A5 (ja)
IT (1) IT1216814B (ja)
PT (1) PT84943B (ja)
ZA (1) ZA873841B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005237580B2 (en) * 2004-04-28 2011-06-16 Procarrier, Inc. Oral formulation for delivery of poorly absorbed drugs
TW200950801A (en) 2008-05-07 2009-12-16 Merrion Res Iii Ltd Compositions of peptides and processes of preparation thereof
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption

Also Published As

Publication number Publication date
JPS62283930A (ja) 1987-12-09
PT84943B (pt) 1990-03-08
IT8747977A0 (it) 1987-05-25
CH669909A5 (ja) 1989-04-28
PT84943A (en) 1987-06-01
IT1216814B (it) 1990-03-14
ZA873841B (en) 1989-01-25

Similar Documents

Publication Publication Date Title
DE69434963T2 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE60021166T2 (de) Neue exendin agonist formulierungen und deren verabreichung
DE60026144T2 (de) Benzamidformulierung mit histon-deacetylase-inhibitoraktivität
DE69429169T2 (de) Pharmazeutisches präparat, das heparin, heparinfragmente oder -derivate in kombination mit glycerinestern enthält
DE69022678T2 (de) S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
DE3318649A1 (de) Zweiphasenformulierung
DE3887494T2 (de) Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel.
DE69511539T2 (de) Eine cyclosporin enthaltende zubereitung und ein verfahren für ihre herstellung
DE3247786A1 (de) Verwendung von peptiden als medikamente
DE3716437A1 (de) Pharmazeutische zusammensetzung
DE3537656C2 (ja)
AT396475B (de) Säureadditionssalze aus amidiertem taurin oder glycin, deren herstellung und verwendung
WO2001087265A2 (de) Pharmazeutische darreichungsform für peptide, verfahren zu deren herstellung und verwendung
DE69508551T2 (de) Verwendung von L-Carnitin und Derivaten zur Verringerung der Toxizität von Cyclosporin-A und anderer Immunosuppressiva
DE69018799T2 (de) IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.
CH680924A5 (ja)
DE69805096T2 (de) Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments
CH667994A5 (de) Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
EP0277462B1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
CH683069A5 (de) Pharmazeutische Somatostatin-Kompositionen mit verbesserter Resorption, deren Herstellung und Verwendung.
DE69227979T2 (de) Modifizierte VIP-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
DE3000139A1 (de) Die verwendung von glyzerinphosphorylderivaten in der therapie der dislipaemie, der hepatitis und vergleichgeeignete pharmazeutische kompositionen
EP0021184B1 (de) Sekretinpräparate mit verstärkter und protrahierter Wirkung, Verfahren zu ihrer Herstellung sowie Dihydroxybenzoyl-L-tyrosin
DE60020939T2 (de) Salze von pharmakologisch aktiven peptiden mit verzögerter wirkstofffreigabe und deren herstellung
DE69125204T2 (de) Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased